Navigation Links
China Sky One Medical, Inc. Signs Distribution Agreement with Harbin Baolong Pharmaceutical Company
Date:7/15/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution 2
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Aware Inc Reports Third Quarter 2009 Financial Results 10445 1Aware Inc Reports Third Quarter 2009 Financial Results 10445 2Aware Inc Reports Third Quarter 2009 Financial Results 10445 3Aware Inc Reports Third Quarter 2009 Financial Results 10445 4Aware Inc Reports Third Quarter 2009 Financial Results 10445 5Aware Inc Reports Third Quarter 2009 Financial Results 10445 6Aware Inc Reports Third Quarter 2009 Financial Results 10445 7Fish Oil Supplements Dont Help Depressed Heart Patients 59851 1Fish Oil Supplements Dont Help Depressed Heart Patients 59851 2Fish Oil Supplements Dont Help Depressed Heart Patients 59851 3Depression in older cancer patients can be effectively treated with collaborative approach 59848 1Depression in older cancer patients can be effectively treated with collaborative approach 59848 2Depression in older cancer patients can be effectively treated with collaborative approach 59848 3